Legal & General Group
ZURA icon

Legal & General Group’s Zura Bio ZURA Stock Holding History

Legal & General Group’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,779
Closed -$6.16K – 3559
2025
Q1 		$6.16K Hold
4,779
– – ﹤0.01% 3250
2024
Q4 		$11.9K Hold
4,779
– – ﹤0.01% 3215
2024
Q3 		$19.4K Buy
4,779
+2,873
+151% +$10.7K ﹤0.01% 3060
2024
Q2 		$6.67K Buy
+1,906
New +$7.77K ﹤0.01% 3354

Other funds holding ZURA

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

Legal & General Group's ZURA Position: Q2 2025 in Review

Legal & General Group sold out of Zura Bio (ZURA) in Q2 2025, closing a stake of 4,779 shares — an estimated $6.16K sold.

Legal & General Group first reported a position in ZURA in Q2 2024 and held it in 4 quarters. The position peaked at $19.4K in Q3 2024. 65 funds tracked by Wall St. Rank hold ZURA as of Q2 2025.

  • Legal & General Group reported no remaining Zura Bio position as of Q2 2025 after selling out during the quarter.
  • Legal & General Group sold 4,779 Zura Bio shares in Q2 2025, an estimated $6.16K.
  • Legal & General Group first reported a position in Zura Bio in Q2 2024 and held it in 4 quarters.
  • Legal & General Group's Zura Bio position peaked at $19.4K in Q3 2024.
  • 65 funds tracked by Wall St. Rank held Zura Bio as of Q2 2025.

Based on Legal & General Group's 13F filing for Q2 2025, filed 12 Aug 2025.